August 2, 2020

“We Need to Move On” from Hydroxychloroquine, Says Trump’s Testing Czar

Adm. Brett Giroir, assistant secretary of Health and Human Services.Alex Brandon/AP

The coronavirus is a rapidly developing news story, so some of the content in this article might be out of date. Check out our most recent coverage of the coronavirus crisis, and subscribe to the Mother Jones Daily newsletter.

The country’s coronavirus testing czar on Sunday tried to put the endless debate over hydroxychloroquine, the president’s preferred coronavirus treatment, to bed. “We need to move on from that and talk about what is effective,” said Brett Giroir, assistant secretary at the Department of Health and Human Services, on NBC’s Meet the Press—contradicting his boss, who is still touting the drug.

For months, President Trump has hyped the anti-malarial drug hydroxychloroquine as a treatment for COVID-19. At one point, Trump even claimed he was taking the drug himself. This past week, Trump’s son Donald Trump Jr. tweeted a viral video showing doctors saying masks are not necessary and that hydroxychloroquine was a proven antidote. Twitter and Facebook took the video down for spreading misinformation, and Twitter suspended Trump Jr.’s ability to tweet for 12 hours. Trump, who also tweeted the video, defended his support of hydroxychloroquine after the video was removed, and said the doctors in the viral video were “very respected.” One of the featured doctors, Stella Immanuel, holds numerous unproven beliefs, including about sex with demons.

Despite Trump’s protestations, Dr. Anthony Fauci said on Wednesday that hydroxychloroquine is not effective. “We know that every single good study—and by good study I mean randomized control study in which the data are firm and believable—has shown that hydroxychloroquine is not effective in the treatment of Covid-19,” he said.

On Sunday, Giroir piled on. “There may be circumstances, I don’t know what they are, where a physician may prescribe it for an individual, but I think most physicians and prescribers are evidence-based and they’re not influenced by whatever is on Twitter or anything else,” he said. “And the evidence just doesn’t show that hydroxychloroquine is effective right now.”

WE CAME UP SHORT.

We just wrapped up a shorter-than-normal, urgent-as-ever fundraising drive and we came up about $45,000 short of our $300,000 goal.

That means we're going to have upwards of $350,000, maybe more, to raise in online donations between now and June 30, when our fiscal year ends and we have to get to break-even. And even though there's zero cushion to miss the mark, we won't be all that in your face about our fundraising again until June.

So we urgently need this specific ask, what you're reading right now, to start bringing in more donations than it ever has. The reality, for these next few months and next few years, is that we have to start finding ways to grow our online supporter base in a big way—and we're optimistic we can keep making real headway by being real with you about this.

Because the bottom line: Corporations and powerful people with deep pockets will never sustain the type of journalism Mother Jones exists to do. The only investors who won’t let independent, investigative journalism down are the people who actually care about its future—you.

And we hope you might consider pitching in before moving on to whatever it is you're about to do next. We really need to see if we'll be able to raise more with this real estate on a daily basis than we have been, so we're hoping to see a promising start.

payment methods

WE CAME UP SHORT.

We just wrapped up a shorter-than-normal, urgent-as-ever fundraising drive and we came up about $45,000 short of our $300,000 goal.

That means we're going to have upwards of $350,000, maybe more, to raise in online donations between now and June 30, when our fiscal year ends and we have to get to break-even. And even though there's zero cushion to miss the mark, we won't be all that in your face about our fundraising again until June.

So we urgently need this specific ask, what you're reading right now, to start bringing in more donations than it ever has. The reality, for these next few months and next few years, is that we have to start finding ways to grow our online supporter base in a big way—and we're optimistic we can keep making real headway by being real with you about this.

Because the bottom line: Corporations and powerful people with deep pockets will never sustain the type of journalism Mother Jones exists to do. The only investors who won’t let independent, investigative journalism down are the people who actually care about its future—you.

And we hope you might consider pitching in before moving on to whatever it is you're about to do next. We really need to see if we'll be able to raise more with this real estate on a daily basis than we have been, so we're hoping to see a promising start.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate